Are the vaccines effective enough?
Our podcast at the sharp end of the global vaccination race. Also this week: a look at Chinese vaccines and the data on how far variants have spread
THREE VACCINES have been approved by stringent regulators. Ten are being used in one or more countries. How do they work and are they effective enough against new variants of the coronavirus?
Sarah Gilbert, inventor of the Oxford-AstraZeneca vaccine, tells us adapting to new variants should be easy. The Economist’s Beijing bureau chief David Rennie reports from China, which faces a huge test of its homegrown vaccine technology as it tries to re-open. James Fransham from our data team on how far the variants have spread.
Alok Jha, The Economist’s science correspondent, hosts with our health policy editor, Natasha Loder. Slavea Chankova, The Economist’s health-care correspondent, joins them. Runtime: 36min
Listen on: Apple Podcasts | Spotify | Google | Stitcher | TuneIn
For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod and sign up for our new weekly science newsletter at economist.com/simplyscience
More from Podcasts
Checks and Balance
Will Donald Trump’s first criminal trial matter?
Our weekly podcast on democracy in America. This week, we take stock of the former president’s hush-money trial
49:10
The Intelligence
Overnight, Israel appears to have retaliated against Iran
Also on the daily podcast: India’s opposition and a tribute to a sumo champion
27:07
Money Talks
Why weight-loss drugs will reshape the world
Our podcast on markets, the economy and business. This week, it’s not just waistlines that could see the benefit from the new “miracle” drugs
36:59